A new method of removing cells (decellularization) from adipose tissue and the use of the obtained preparation in medicine

Summary of the technology

The subject of the offer is a potential method of removing cells (decellularization) from adipose tissue as well as obtained in this way preparation, especially in the form of extracellular matrix (adipoECM) for application in medicine, especially in plastic surgery.

Details of the Technology Offer

A common feature of classic medical biomaterials is their strictly defined composition, which is the result of using purified ingredients. This is how biopolimers biomaterials are made (incl. Integra®DRT), the strictly defined composition of which enables large-scale production. Also the administrative processes related to the implementation of such a medical device are widely known. On the other hand, in the case of medical biomaterials produced from cell-free (decellularized) natural tissues, the starting material is shaped human tissue, from which, during preparation, cells and some components of the extracellular matrix (ECM) are removed. The result is a tissue-specific ECM that consists of major structural proteins and components that make up the biochemical context of the original tissue. Thanks to this, decellularized tissues obtain a specific molecules that, for example, promote adipogenesis, i.e. the creation of new cells that build adipose tissue.

Decellularization of adipose tissue is time-consuming due to the high content of lipids. There are currently two main methods in use. The former is based on the use of detergents (e.g. Triton X-100) and digestion of nucleic acids with DNase, while the latter uses sequential digestion with trypsin with isopropyl alcohol washing, combined with enzymatic degradation of nucleic acids and lipids. Both methods enable to produce decellularized adipose tissue with a DNA content of less than 50 μg / mg dry weight and without the presence of lipids, usually taking about seven days.

In order to meet these difficulties, a new invention on the Jagiellonian University, which constitutes this offer, has been developed. Its subject is an innovative technology of obtaining decellularized adipose tissue. Compared to the previous techniques mentioned above, the developed method is characterized in particular by a short preparation time (maximum two days), the use of readily available reagents, and above all - the use of a widely lipoaspirate, available after plastic surgery. In addition, this method is characterized by low hardware requirements and a simple methodology for quality assessment.

Thanks to the development of a new technology, the obtained new preparation - a biomaterial, especially in the form of an extracellular matrix (adipoECM) - is distinguished by the following advantages:

  • injectable form is in the form of small and solid fragments of biomaterial;
  • the acellular form does not contain cells, therefore it does not undergo necrosis like fat fragments in the popular method of tissue augmentation using liposuction (so-called lipotransfer);
  • shows a high potential of healing , promoting angiogenesis and spontaneous adipogenesis, which gives a chance to maintain permanent filling and tissue reconstruction effect;
  • is not immunogenic;
  • has proven biocompatibility in in vitro and in vivo systems, as well as conducted biochemical and biophysical characteristics, what constitutes product documentation;
  • does not require registration as a medical device, because under the applicable law it is a biostatic transplant.

    The offered solution is patent pending.

    Further work on its development is carried out by scientists from the Faculty of Medicine of the Jagiellonian University Medical College and the Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University.

Intellectual property status

  • Patent already applied for
  • Patent application number :P.438204

Related Keywords

  • Biological Sciences
  • Medicine, Human Health
  • Medical Biomaterials
  • Biology / Biotechnology
  • Other Medical/Health Related
  • decellularization

About Jagiellonian University

Jagiellonian University, founded 1364, is the oldest university in Poland and one of the oldest worldwide. The research and teaching activities are conducted at 15 faculties, including the Medical College (Collegium Medicum). Over 3,700 researchers work at the university and the total number of students is about 50,000.

Beata Strach

Never miss an update from Beata Strach

Create your free account to connect with Beata Strach and thousands of other innovative organizations and professionals worldwide


Send a request for information
to Beata

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.


Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support